| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10753-016-0412-5 |
| P698 | PubMed publication ID | 27473158 |
| P50 | author | Payam Akhyari | Q51066626 |
| P2093 | author name string | Antonio Pinto | |
| Artur Lichtenberg | |||
| Udo Boeken | |||
| Alexander Jenke | |||
| Annika Jahn | |||
| Moritz Benjamin Immohr | |||
| Laura Döhrn | |||
| Markus Kornfeld | |||
| P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
| Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor | Q28082430 | ||
| Oral everolimus inhibits in-stent neointimal growth | Q28194046 | ||
| Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks | Q28255399 | ||
| Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression | Q28571168 | ||
| Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis | Q28585415 | ||
| Degree of hypothermia in aortic arch surgery - optimal temperature for cerebral and spinal protection: deep hypothermia remains the gold standard in the absence of randomized data | Q30663478 | ||
| Combined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscle | Q33233109 | ||
| Clinical pharmacokinetics of everolimus | Q33358752 | ||
| Immunoregulatory functions of mTOR inhibition. | Q33761278 | ||
| Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy | Q33917765 | ||
| Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. | Q33954952 | ||
| Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors | Q34010378 | ||
| Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature | Q34297088 | ||
| Modern temperature management in aortic arch surgery: the dilemma of moderate hypothermia | Q34341860 | ||
| S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. | Q35220422 | ||
| The systemic inflammatory response to cardiopulmonary bypass | Q35561177 | ||
| Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues | Q35584938 | ||
| Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells. | Q35780238 | ||
| The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes | Q35804133 | ||
| The pleiotropic effects of mTor inhibitors | Q35981412 | ||
| Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation | Q36302824 | ||
| Modulation of systemic inflammatory response after cardiac surgery | Q36320195 | ||
| Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart | Q37256152 | ||
| Everolimus: efficacy and safety in cardiac transplantation | Q37779322 | ||
| The innate immune response in reperfused myocardium | Q37977824 | ||
| Proliferation signal inhibitor toxicities after thoracic transplantation | Q38044748 | ||
| Corticosteroids for the inflammatory response to cardiopulmonary bypass: an update | Q38066285 | ||
| Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery | Q38070454 | ||
| The role of everolimus in liver transplantation | Q38248591 | ||
| Acute kidney injury in severe sepsis: pathophysiology, diagnosis, and treatment recommendations | Q38407334 | ||
| Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation | Q39732644 | ||
| The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand | Q39785346 | ||
| Perioperative Dynamics of TLR2, TLR4, and TREM-1 Expression in Monocyte Subpopulations in the Setting of On-Pump Coronary Artery Bypass Surgery | Q41836365 | ||
| Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase | Q42062495 | ||
| A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage. | Q43004985 | ||
| Effects of everolimus on cytokines, oxidative stress, and renal histology in ischemia-reperfusion injury of the kidney | Q43265105 | ||
| Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model | Q44068719 | ||
| Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats | Q44734358 | ||
| Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery. | Q45938003 | ||
| Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells | Q46314249 | ||
| Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place | Q46420426 | ||
| Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia | Q46916538 | ||
| Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. | Q48823158 | ||
| Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. | Q51434203 | ||
| Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. | Q53201792 | ||
| Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. | Q53378752 | ||
| Effect of rapamycin on the expression of the IL-2 receptor (CD25) | Q70909270 | ||
| Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion | Q72850594 | ||
| An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts | Q72941484 | ||
| Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid | Q83466246 | ||
| IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis | Q84972123 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 1771-1782 | |
| P577 | publication date | 2016-07-29 | |
| P1433 | published in | Inflammation | Q2560341 |
| P1476 | title | Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model. | |
| P478 | volume | 39 |
| Q55480734 | Hydrogen-rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus-activated kinase 2/signal transducer and activator of transcription 3 signaling pathway. |
| Q92059551 | Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass |
Search more.